Trine Opstad Andersen

581 total citations
10 papers, 279 citations indexed

About

Trine Opstad Andersen is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Trine Opstad Andersen has authored 10 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Genetics. Recurrent topics in Trine Opstad Andersen's work include Hormonal and reproductive studies (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Menopause: Health Impacts and Treatments (4 papers). Trine Opstad Andersen is often cited by papers focused on Hormonal and reproductive studies (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Menopause: Health Impacts and Treatments (4 papers). Trine Opstad Andersen collaborates with scholars based in Norway, Netherlands and Germany. Trine Opstad Andersen's co-authors include Per Morten Sandset, Leiv Sandvik, Ingrid Os, Else Høibraaten, Anders Erik Astrup Dahm, Bjørn Bendz, F. R. Rosendaal, Per Ole Iversen, Elisabeth Qvigstad and Nils Hjeltnes and has published in prestigious journals such as The Lancet, British Journal of Haematology and Journal of Thrombosis and Haemostasis.

In The Last Decade

Trine Opstad Andersen

10 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trine Opstad Andersen Norway 9 97 93 79 65 55 10 279
Marie‐Thérèse Blouch France 7 83 0.9× 186 2.0× 142 1.8× 69 1.1× 45 0.8× 9 380
Erica Malan Australia 7 53 0.5× 120 1.3× 81 1.0× 83 1.3× 93 1.7× 9 296
Marinka S. Post Netherlands 8 28 0.3× 223 2.4× 159 2.0× 30 0.5× 58 1.1× 8 395
B. Hentschel Germany 9 35 0.4× 96 1.0× 31 0.4× 26 0.4× 64 1.2× 11 328
R. A. Ajjan United Kingdom 6 34 0.4× 102 1.1× 22 0.3× 13 0.2× 93 1.7× 9 301
Michelle Bignell United States 8 210 2.2× 23 0.2× 35 0.4× 46 0.7× 38 0.7× 8 587
M. Myśliwiec Poland 9 32 0.3× 13 0.1× 29 0.4× 32 0.5× 39 0.7× 30 261
A. L. Tranquilli Italy 10 15 0.2× 32 0.3× 24 0.3× 4 0.1× 27 0.5× 17 313
Gündeniz Altıay Türkiye 6 18 0.2× 25 0.3× 8 0.1× 63 1.0× 41 0.7× 26 246
Steffen K. Geberth Germany 11 19 0.2× 16 0.2× 353 4.5× 9 0.1× 36 0.7× 13 513

Countries citing papers authored by Trine Opstad Andersen

Since Specialization
Citations

This map shows the geographic impact of Trine Opstad Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trine Opstad Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trine Opstad Andersen more than expected).

Fields of papers citing papers by Trine Opstad Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trine Opstad Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trine Opstad Andersen. The network helps show where Trine Opstad Andersen may publish in the future.

Co-authorship network of co-authors of Trine Opstad Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Trine Opstad Andersen. A scholar is included among the top collaborators of Trine Opstad Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trine Opstad Andersen. Trine Opstad Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sandvik, Leiv, et al.. (2006). Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thrombosis Research. 120(3). 371–379. 29 indexed citations
2.
Qvigstad, Elisabeth, et al.. (2006). Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. Maturitas. 55(3). 278–287. 28 indexed citations
3.
Dahm, Anders Erik Astrup, Frits R. Rosendaal, Trine Opstad Andersen, & Per Morten Sandset. (2005). Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state. British Journal of Haematology. 132(3). 333–338. 10 indexed citations
4.
Dahm, Anders Erik Astrup, Trine Opstad Andersen, F. R. Rosendaal, & Per Morten Sandset. (2005). A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI). Journal of Thrombosis and Haemostasis. 3(4). 651–658. 29 indexed citations
5.
6.
Iversen, Per Ole, et al.. (2002). Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia. British Journal of Haematology. 119(4). 1011–1016. 38 indexed citations
7.
Bendz, Bjørn, Morten Rostrup, Knut Sevre, Trine Opstad Andersen, & Per Morten Sandset. (2001). Hypobaric hypoxia. The Lancet. 357(9260). 955–956. 3 indexed citations
8.
Bendz, Bjørn, Trine Opstad Andersen, & Per Morten Sandset. (2000). A New Sensitive Chromogenic Substrate Assay of Tissue Factor Pathway Inhibitor Type 1. Thrombosis Research. 97(6). 463–472. 28 indexed citations
9.
Høibraaten, Else, et al.. (2000). The Effects of Hormone Replacement Therapy on Hemostatic Variables in Women with Angiographically Verified Coronary Artery Disease. Thrombosis Research. 98(1). 19–27. 36 indexed citations
10.
Hansen, John‐Bjarne, et al.. (1999). Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins. British Journal of Haematology. 107(4). 756–762. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Thérèse Blouch Breakdown of academic impact, for papers by Erica Malan Breakdown of academic impact, for papers by Marinka S. Post Breakdown of academic impact, for papers by B. Hentschel Breakdown of academic impact, for papers by R. A. Ajjan Breakdown of academic impact, for papers by Michelle Bignell Breakdown of academic impact, for papers by M. Myśliwiec Breakdown of academic impact, for papers by A. L. Tranquilli Breakdown of academic impact, for papers by Gündeniz Altıay Breakdown of academic impact, for papers by Steffen K. Geberth
Rankless by CCL
2026